News about Market

Global Study Identifies Most Effective Strategies to Increase Vaccine Uptake

Research in The BMJ finds that expanded access, community engagement, and financial incentives significantly improve vaccination rates across age groups and underserved populations.

Market | 17/04/2026 | By News Bureau |  148

GSK Acquires 100 Percent Equity of 35Pharma for USD 950 Million

GSK completes acquisition of 35Pharma, adding HS235, a potential best-in-class therapy for Pulmonary Hypertension.

Market | 16/04/2026 | By News Bureau |  169

PrecisionLife and Ovation Partner to Launch GLP-1 stratification LDT and GLP-1 DNA Test in H2 2026

PrecisionLife and Ovation partner to launch GLP-1 stratification LDT and consumer DNA test in 2026, with early data showing distinct genetic markers for weight loss and glycemic control.

Market | 16/04/2026 | By News Bureau |  184

MSN Laboratories Launches SEMABEST, India's First Semaglutide After Patent Expiry

MSN Laboratories launches SEMABEST, India’s first semaglutide post patent expiry, priced 50 percent lower than the innovator drug and available as a pre-filled pen for improved patient access.

Market | 15/04/2026 | By News Bureau |  356

Oncodesign Services Expands Collaboration with GIP ARRONAX to Advance Targeted Radiotherapy Research

Oncodesign Services strengthens partnership with GIP ARRONAX to secure access to rare radionuclides like astatine-211, supporting preclinical development of next-generation targeted radiotherapy treatments for cancer and other diseases.

Market | 14/04/2026 | By News Bureau |  226

ImageneBio Raises USD 30 Million in Private Placement

ImageneBio has raised USD 30 million in private placement led by Coastlands Capital to advance IMG-007 development in alopecia areata and atopic dermatitis.

Market | 14/04/2026 | By News Bureau |  133

ANI Pharmaceuticals Launches Carbamazepine Extended-Release Capsules

ANI Pharmaceuticals launches Carbamazepine extended-release capsules, a generic version of Carbatrol.

Market | 13/04/2026 | By News Bureau |  168

IASO Biotechnology Partners with Instituto Butantan to Localise CAR-T Therapy in Brazil

IASO Bio licenses CAR-T technology to Instituto Butantan for local development in Brazil, aiming to reduce treatment costs and expand public access to advanced therapies for haematological cancer patients.

Market | 13/04/2026 | By News Bureau |  257

Croma-Pharma Acquires Synocrom, Re-Enters Orthopaedics

Croma-Pharma acquires Synocrom to re-enter orthopaedics, expanding its portfolio with a hyaluronic acid treatment for knee osteoarthritis launching in the EU and Switzerland in May 2026.

Market | 10/04/2026 | By News Bureau |  216

Forte Biosciences Announces Pricing of USD 150 Million Public Offering

Forte Biosciences announces pricing of its USD 150 million public offering, with expected gross proceeds of USD 150 million before underwriting discounts, commissions, and offering expenses.

Market | 10/04/2026 | By News Bureau |  179